BSE - Delayed Quote INR

Supriya Lifescience Limited (SUPRIYA.BO)

628.60
-7.60
(-1.19%)
At close: May 9 at 3:29:30 PM GMT+5:30
Loading Chart for SUPRIYA.BO
  • Previous Close 636.20
  • Open 607.75
  • Bid 628.65 x --
  • Ask 630.30 x --
  • Day's Range 607.75 - 638.10
  • 52 Week Range 330.50 - 841.70
  • Volume 15,685
  • Avg. Volume 32,227
  • Market Cap (intraday) 50.591B
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 29.02
  • EPS (TTM) 21.66
  • Earnings Date --
  • Forward Dividend & Yield 0.80 (0.13%)
  • Ex-Dividend Date Sep 20, 2024
  • 1y Target Est 740.00

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

www.supriyalifescience.com

448

Full Time Employees

March 31

Fiscal Year Ends

Recent News: SUPRIYA.BO

View More

Performance Overview: SUPRIYA.BO

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SUPRIYA.BO
15.04%
S&P BSE SENSEX (^BSESN)
1.68%

1-Year Return

SUPRIYA.BO
70.95%
S&P BSE SENSEX (^BSESN)
9.74%

3-Year Return

SUPRIYA.BO
79.41%
S&P BSE SENSEX (^BSESN)
45.87%

5-Year Return

SUPRIYA.BO
47.91%
S&P BSE SENSEX (^BSESN)
151.10%

Compare To: SUPRIYA.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SUPRIYA.BO

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    50.68B

  • Enterprise Value

    49.87B

  • Trailing P/E

    29.07

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.71

  • Price/Book (mrq)

    5.59

  • Enterprise Value/Revenue

    7.58

  • Enterprise Value/EBITDA

    19.23

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.02%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.71B

  • Net Income Avi to Common (ttm)

    1.75B

  • Diluted EPS (ttm)

    21.66

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    843.14M

  • Total Debt/Equity (mrq)

    0.61%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: SUPRIYA.BO

View More

Company Insights: SUPRIYA.BO

Research Reports: SUPRIYA.BO

View More

People Also Watch